TrialInvestigational new drugs2016

Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3-1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects.

C E Halstenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.